WellDoc Launches BlueStar, First FDA-Cleared, Mobile Prescription Therapy for Type 2 Diabetes with Insurance Reimbursement

Business Wire
Share
Thursday, June 13th 2013

Ford®, Rite Aid, and other Great American Companies Lead the Way by Offering the Innovative mHealth Therapy as Part of their Prescription Health Benefits

Advanced

Today, at the 2nd annual Digital Health Summer Summit, WellDoc®, a healthcare behavioral science and technology company, announced the launch of BlueStar™, a new product in a novel class of diabetes therapy. BlueStar will be reimbursed and adjudicated as a pharmacy benefit similar to other prescription products and will be available this summer in select areas followed by a nationwide launch later this year. In coordination with the launch, Ford Motor Company, Rite Aid, DexCom plus other Fortune 500 companies announced their employees and covered dependents will be among the first to have reimbursed access to BlueStar. Each of the companies is adding the product to its prescription benefit plans, which are managed by various health plans and pharmacy benefits managers.

“Healthcare is on the cusp of a revolution where new technologies can address epidemics, like diabetes, in ways never before imagined,” said Rick Popp, director of employee benefits at Ford Motor Company. “We are excited about the possibilities of a product like BlueStar that may benefit our employees who face the daily challenges of living with type 2 diabetes. It’s another example of Ford going further.”

BlueStar is a patient-centered medical product that requires a prescription from a licensed healthcare provider and is cleared by the FDA for use by adults with type 2 diabetes. BlueStar is powered by the proprietary WellDoc Automated Expert Analytics System™ and provides real-time motivational, behavioral and educational coaching to help patients self-manage their diabetes treatment plan.

“Giving patients access to a prescribed mobile therapy that helps tailor treatment to an individual’s needs and their physician’s orders may prove to be a major advancement in diabetes management.” explained Richard Bergenstal M.D. executive director at the International Diabetes Center at Park Nicollet and former president of the American Diabetes Association. “In the era of healthcare reform, it’s important that payers recognize that patients must have access to proven, novel digital tools.”

BlueStar supports patients through smart blood glucose testing, healthy diet and exercise choices, medication adherence, and quality standards of care such as A1c tests, foot exams, and blood pressure and lipid levels. Additionally, BlueStar provides the patients’ physicians with clinical decision support and enables them to efficiently extend care beyond traditional office visits.

“At Rite Aid, we’re committed to offering our associates a robust benefits package, ensuring they and their families have the tools, resources and support to help guide their healthcare decisions,” explained Ken Black, Rite Aid group vice president of compensation, benefits and shared services. “Through the use of innovations such as BlueStar, we can provide covered Rite Aid associates and their eligible family members living with type 2 diabetes a useful tool that improves quality of care and supports healthier living.”

According to the American Diabetes Association, there are 25.8 million people in the U.S. with diabetes, or 8.3% of the population. The total estimated cost of diagnosed diabetes in 2012 was $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity.

BlueStar works on feature and smartphone platforms, tablets and desktops to help patients comply with their treatment protocols while also analyzing important data to assist clinicians in developing personalized care plans. It is supported by a national network of trainers who work with patients to introduce them to the product and make sure they fully understand its operability.

Contacts

For WellDoc:
Tim Stanton, 202-223-4933
tstanton@stantoncomm.com
or
WellDoc
Demir Bingol
VP, Commercial Marketing
dbingol@welldocinc.com

Business Wire logo Copyright (2013) Business Wire.
All Rights Reserved.